Immunosuppressive Agents: all 5,940 studies that test it
Page 60 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationCompletedNCT00002456Phase 3
- A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAARTCompletedNCT00002392Not applicable
- Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected PatientsCompletedNCT00002174Not applicable
- Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting SyndromeCompletedNCT00002157Not applicable
- A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting SyndromeCompletedNCT00002127Phase 2
- Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIVCompletedNCT00002104Phase 1
- Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)CompletedNCT00001965Phase 2
- Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
- Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)CompletedNCT00001955Phase 2
- Etanercept Therapy for Sjogren's SyndromeCompletedNCT00001954Phase 2
- Zenapax to Treat Multiple SclerosisCompletedNCT00001934Phase 2
- Etanercept to Treat Wegener's GranulomatosisCompletedNCT00001901Phase 2
- Study of TNFR:Fc (Enbrel) in the Treatment of AsthmaCompletedNCT00001893Phase 2
- HAT in Eye Complications of Behcet's DiseaseCompletedNCT00001865Phase 2
- Leflunomide to Treat UveitisCompletedNCT00001863Phase 2
- TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid ArthritisCompletedNCT00001862Phase 2
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
- Cyclosporin Implant to Treat UveitisCompletedNCT00001737Phase 1
- Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsCompletedNCT00001731Phase 2
- A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus ErythematosusCompletedNCT00001680Phase 2
- Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and EfficacyCompletedNCT00001677Phase 2
- Comparing Therapies for the Treatment of Severe Aplastic AnemiaCompletedNCT00001626Phase 2
- Pilot Study of Thalidomide to Treat Sjogren's SyndromeCompletedNCT00001599Phase 2
- A Phase I Study of SU101 in Pediatric Patients With Refractory MalignancyCompletedNCT00001573Phase 1
- Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With CyclosporineCompletedNCT00001533Phase 1
- ANTI-TAC THERAPY FOR UVEITISCompletedNCT00001526Phase 1
- Thalidomide to Treat Oral Lesions in HIV-Infected PatientsCompletedNCT00001524Phase 2
- A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerCompletedNCT00001446Phase 2
- A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2
- A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer PatientsCompletedNCT00001384Phase 2
- Steroids and Methotrexate to Treat Systemic VasculitisCompletedNCT00001256Phase 2
- Treatment of Wegener's Granulomatosis With CyclophosphamideCompletedNCT00001155Phase 2
- A Study To Test An Anti-Rejection Therapy After Kidney TransplantationTerminatedNCT00000936Phase 3
- A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV DiseaseCompletedNCT00000880Phase 2
- A Phase I Study of Methotrexate for HIV InfectionCompletedNCT00000834Phase 1
- A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 InfectionCompletedNCT00000812Phase 1
- A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected SubjectsCompletedNCT00000792Phase 1
- Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV InfectionCompletedNCT00000790Phase 2
- A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 LymphocytesCompletedNCT00000645Phase 1